BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes (OTTAWA, ON – September 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration (FDA) to request approval of its technetium-99m (Tc-99m) generator for […]
BWXT Names Robert Duffy as Chief Administrative Officer
(LYNCHBURG, Va. – August 22, 2022) – BWX Technologies, Inc. (NYSE: BWXT) has appointed Robert (Bob) Duffy as senior vice president and chief administrative officer (CAO). In this role, he will have full responsibility for human resources and a number of other business support functions. “Bob has an extraordinary track record of leading and building […]
BWX Technologies Reports Robust Second Quarter 2022 Results
LYNCHBURG, Va.–(BUSINESS WIRE)– BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported second quarter 2022 revenue of $554 million, a 10% increase compared with $505 million in the second quarter 2021. GAAP net income for the second quarter 2022 was $74.6 million, or $0.82 per diluted share, compared with net income of $59.3 […]
BWXT Names Sharon H. Smoot as President of Nuclear Operations Group
(LYNCHBURG, Va. – July 27, 2022) – BWX Technologies, Inc. (NYSE: BWXT) has appointed Sharon H. Smoot as president of BWXT’s Nuclear Operations Group, Inc. (NOG). In this role, she will have full responsibility for NOG’s mission to provide a complete range of nuclear components and services, including the manufacture of nuclear reactor components for […]
BWX Technologies to Announce Second Quarter 2022 Results on Monday, August 8
LYNCHBURG, Va.–(BUSINESS WIRE)– BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing second quarter 2022 results on Monday, August 8, 2022, after market close and will host a conference call at 5:00 p.m. EDT. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors. The dial-in numbers for participants […]
BWXT Canada Awarded CA$130 Million Component Manufacturing Contract from Bruce Power
(CAMBRIDGE, Ontario – July 5, 2022) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract awarded by Bruce Power valued at approximately CA$130 million in support of Bruce Power’s Major Component Replacement (MCR) Project. The contract is for the fabrication and supply of replacement feeders for Bruce Power’s reactor units 3, 4, 5, 7 […]
BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
(OTTAWA, ON – June 27, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has executed a commercial agreement with Bayer AG (Bayer) to supply high-purity Actinium-225 (Ac-225). Today’s announcement follows the agreement reached by the two companies in September 2021. Under the terms of the commercial agreement, Bayer will […]
BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
(OTTAWA, ON – June 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and services agreement that strengthens their existing partnership for the production of medical isotopes. This agreement will enable BWXT Medical to manufacture high purity Actinium-225 (Ac-225) […]
BWXT to Build First Advanced Microreactor in United States
U.S. Department of Defense Strategic Capabilities Office Selects BWXT to Manufacture and Deliver Project Pele Prototype Reactor to Idaho National Laboratory in 2024 (LYNCHBURG, Va. – June 9, 2022) – BWX Technologies, Inc. (NYSE: BWXT) will build the first advanced nuclear microreactor in the United States under a contract awarded by the U.S. Department of […]
BWXT Names Ryan Colvert as Senior Director for Government Relations
(LYNCHBURG, Va. – May 16, 2022) – BWX Technologies, Inc. (NYSE: BWXT) has hired Ryan B. Colvert as a senior director for government relations. Colvert will focus on BWXT’s relationships with the U.S. Congress and the executive branch related to the company’s role as the sole manufacturer of naval nuclear reactors for U.S. submarines and aircraft […]
